These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7704512)

  • 1. Impact of prognostic factors on endpoints for clinical studies.
    Sørensen JB
    Lung Cancer; 1994 Nov; 11 Suppl 3():S45-54. PubMed ID: 7704512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of PCNA expression in non-small cell lung cancer].
    Dworakowska D
    Pneumonol Alergol Pol; 2005; 73(3):292-6. PubMed ID: 16989169
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic value of CD4+ pleural cavity lymphocytes in non-small cell lung cancer].
    Takahashi K
    Nihon Rinsho; 2002 May; 60 Suppl 5():272-5. PubMed ID: 12101671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunobiology of the non-small-cell lung carcinoma: new aspects].
    Fischer JR; Neuner A; Muley T; Lahm H; Drings P
    Onkologie; 2001 Sep; 24 Suppl 5():72-4. PubMed ID: 11600817
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic assay in small, node-negative non-small cell lung cancer.
    Anile M; Venuta F
    JAMA; 2013 Feb; 309(8):769. PubMed ID: 23443436
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic assay in small, node-negative non-small cell lung cancer--reply.
    Mann MJ; Jablons DM; Kratz JR
    JAMA; 2013 Feb; 309(8):769-70. PubMed ID: 23443437
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating miRNA signatures: promising prognostic tools for cancer.
    Heneghan HM; Miller N; Kerin MJ
    J Clin Oncol; 2010 Oct; 28(29):e573-4; author reply e575-6. PubMed ID: 20697097
    [No Abstract]   [Full Text] [Related]  

  • 8. EGFR: a prognostic and/or a predictive marker?
    Hirsch FR
    J Thorac Oncol; 2006 Jun; 1(5):395-7. PubMed ID: 17409888
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
    Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
    Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation in lung cancer.
    Park IK
    N Engl J Med; 2008 Jun; 358(23):2513; author reply 2514. PubMed ID: 18536092
    [No Abstract]   [Full Text] [Related]  

  • 11. A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.
    Kratz JR; Van den Eeden SK; He J; Jablons DM; Mann MJ
    JAMA; 2012 Oct; 308(16):1629-31. PubMed ID: 23093159
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of CD4+ lymphocytes in pleural cavity of patients with non-small cell lung cancer.
    Takahashi K; Saito S; Kamamura Y; Katakawa M; Monden Y
    Thorax; 2001 Aug; 56(8):639-42. PubMed ID: 11462067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining prognosis in non-small-cell lung cancer.
    Sun Z; Yang P
    N Engl J Med; 2007 Jan; 356(2):189-90; author reply 190-1. PubMed ID: 17215540
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
    Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-gene signature in non-small-cell lung cancer.
    Gounaris I
    N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436431
    [No Abstract]   [Full Text] [Related]  

  • 17. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
    Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-gene signature in non-small-cell lung cancer.
    Raz DJ; Jablons DM
    N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436432
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer.
    Stahel RA
    Lung Cancer; 1994 Nov; 11 Suppl 3():S31-8. PubMed ID: 7704510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.